43 Cardiac outcomes in Fabry disease References 1. Brady, R.O., et al., Enzymatic Defect in Fabry’s Disease. 1967. 276(21): p. 1163-1167. 2. Kint, J.A., Fabry’s Disease: Alpha-Galactosidase Deficiency. 1970. 167(3922): p. 1268-1269. 3. Mehta, A., et al., Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survey. 2009. 46(8): p. 548-552. 4. Germain, D.P.J.O.J.o.R.D., Fabry disease. 2010. 5(1): p. 30. 5. Mehta, A., et al., Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. 2004. 34(3): p. 236-242. 6. Smid, B.E., et al., Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. J Med Genet, 2015. 52(4): p. 262-8. 7. Arends, M., et al., Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. J Am Soc Nephrol, 2017. 28(5): p. 1631-1641. 8. von Scheidt, W., et al., An atypical variant of Fabry’s disease with manifestations confined to the myocardium. N Engl J Med, 1991. 324(6): p. 395-9. 9. Nakao, S., et al., An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med, 1995. 333(5): p. 288-93. 10. Sachdev, B., et al., Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation, 2002. 105(12): p. 1407-11. 11. Nordin, S., et al., Proposed Stages of Myocardial Phenotype Development in Fabry Disease. JACC Cardiovasc Imaging, 2018. 12. Nordin, S., et al., Cardiac Phenotype of Prehypertrophic Fabry Disease. Circ Cardiovasc Imaging, 2018. 11(6): p. e007168. 13. Wilson, H.C., et al., Arrhythmia and Clinical Cardiac Findings in Children With Anderson- Fabry Disease. Am J Cardiol, 2017. 120(2): p. 251-255. 14. Weidemann, F., et al., Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy. Am J Cardiol, 2016. 118(2): p. 264-74. 15. Baig, S., et al., Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. Europace, 2017. 16. Frustaci, A., et al., Microvascular angina as prehypertrophic presentation of Fabry disease cardiomyopathy. Circulation, 2014. 130(17): p. 1530-1. 17. Chimenti, C., et al., Angina in fabry disease reflects coronary small vessel disease. Circ Heart Fail, 2008. 1(3): p. 161-9. 18. Liu, D., et al., Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease. Open Heart, 2018. 5(2): p. e000803. 19. Sene, T., et al., Cardiac device implantation in Fabry disease: A retrospective monocentric study. Medicine (Baltimore), 2016. 95(40): p. e4996. 20. Bodary, P.F., J.A. Shayman, and D.T. Eitzman, α-Galactosidase A in Vascular Disease.Trends in Cardiovascular Medicine, 2007. 17(4): p. 129-133. 2
RkJQdWJsaXNoZXIy MTk4NDMw